source
- TROP2 scoring and MTAP loss emerge as key biomarkers for NSCLC treatment decisionsResearchers are highlighting two molecular features-TROP2 expression and loss of the MTAP enzyme-as potential guides for therapy in non‑small cell lung cancer. Quantitative scoring of TROP2 by pat…
- Three years of falling overdose deaths spark cautious optimism amid lingering concernsOver the past three years, the United States has seen a steady decline in overdose deaths, a trend that has generated cautious optimism among public‑health observers. While the numbers are encourag…